Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance-Reference-Cited by-同舟云学术

Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance

Published:2023-08 Issue: Volume:248 Page:108459
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Miners John O.,Polasek Thomas M.,Hulin Julie-Ann,Rowland Andrew,Meech Robyn

Funder

U.S. Food and Drug Administration

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference567 articles.

1. Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers;Abel;British Journal of Clinical Pharmacology,2008

2. Probenecid impairment of acetaminophen and lorazepam clearance: Direct inhibition of ether glucuronide formation;Abernethy;Journal of Pharmacology and Experimental Therapeutics,1985

3. Lorazepam and oxazepam kinetics in women on low dose oral contraceptives;Abernethy;Clinical Pharmacology and Therapeutics,1983

4. The human multidrug resistance protein 4 (MRP4, ABCC4): Functional analysis of a highly polymorphic gene;Abla;Journal of Pharmacology and Experimental Therapeutics,2008

5. Safety and efficacy of sorafenib in patients with hepatocellular carcinoma (HCC) and Child-Pugh A versus B cirrhosis;Abou-Alfa;Gastrointestinal Cancer Research,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A high-affinity fluorescent probe for human uridine-disphosphate glucuronosyltransferase 1A9 function monitoring under environmental pollutant exposure;Journal of Hazardous Materials;2024-03

2. UDP-Glycosyltransferases;Reference Module in Biomedical Sciences;2024

3. The expert clinical pharmacological advice program for tailoring on real-time antimicrobial therapies with emerging TDM candidates in special populations: how the ugly duckling turned into a swan;Expert Review of Clinical Pharmacology;2023-10-30

4. Physiologically-Based Pharmacokinetic Modeling for Drugs Cleared by Non-Cytochrome P450 Enzymes: State-of-the-Art and Future Perspectives;Drug Metabolism and Disposition;2023-10-25

5. A High-Affinity Fluorescent Probe for Human Ugt1a9 Function Monitoring Under Environmental Pollutants Exposure;2023